GPX4 and cancer: In certain cancer cells, the formation of the ATG12‐ATG5‐ATG16L1 complex and the subsequent degradation of GPX4 induced by ferroptosis activators (such as erastin or RSL3) requires the involvement of TMEM164 (Liu, Liu, et al. 2023).